Loading…
Revolution Medicines, Inc. is projected to rise to $246.20 by 2027, a +32% move from its current price of $186.88. RVMD is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/13/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 14 | $183.01 | $187.03 | $191.14 | +0.08% |
| Jul 15 | $181.51 | $187.18 | $193.02 | +0.16% |
| Jul 16 | $180.41 | $187.33 | $194.52 | +0.24% |
| Jul 17 | $179.50 | $187.48 | $195.81 | +0.32% |
| Jul 18 | $178.73 | $187.63 | $196.97 | +0.40% |
| Jul 19 | $178.04 | $187.78 | $198.05 | +0.48% |
| Jul 20 | $177.43 | $187.93 | $199.05 | +0.56% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $177.43 | $187.93 | $199.05 | +0.56% |
| Week 2 | $174.22 | $188.99 | $205.00 | +1.13% |
| Week 3 | $172.03 | $190.05 | $209.95 | +1.69% |
| Week 4 | $170.35 | $191.11 | $214.41 | +2.27% |
| Week 5 | $169.00 | $192.19 | $218.56 | +2.84% |
| Week 6 | $167.87 | $193.27 | $222.51 | +3.42% |
| Week 7 | $166.92 | $194.35 | $226.30 | +4.00% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Revolution Medicines, Inc. is a clinical-stage precision oncology company that develops novel targeted therapies for RAS-addicted cancers. Its RAS(ON) inhibitors include daraxonrasib (RMC-6236), elironrasib G12C (RMC-6291) which is in early clinical development for the treatment of solid tumors, and zoldonrasib G12D (RMC-9805), which are in phase 3 registrational trial evaluating the combination of daraxonrasib with zoldonrasib in patients with 1L PDAC; development candidates comprise RMC-5127 (G12V) which is in clinical trial, RMC-0708 (Q61H), that is in clinical trial; and RMC-8839 (G13C).
Revolution Medicines, Inc. was incorporated in 2014 and is headquartered in Redwood City, California.
RVMD is the Revolution Medicines, Inc. stock, traded with a current price of $192.62 and a market cap of $40.95B. It ranks 347 by market cap among equities in its sector. The price outlook combines a solid near-term setup with a long-run bull case, as reflected in the multi-year forecast that envisions meaningful upside through 2030 and well beyond.
The forecast shows the average price rising over time, with increasingly large potential returns in later years.
A major floor 50.5% below — a decisive break under it would weaken the trend.
The nearest floor, 22.8% below — buyers have tended to step in here.
The nearest ceiling, 3.1% above — a clean break opens room to run.
A major ceiling 19.3% above — clearing it would confirm fresh momentum.
Key RVMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of RVMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $189.65 | Sell | $188.68 | Sell |
| MA 10 | $188.70 | Sell | $185.75 | Buy |
| MA 20 | $175.54 | Buy | $177.99 | Buy |
| MA 50 | $159.71 | Buy | $160.91 | Buy |
| MA 100 | $134.45 | Buy | $140.80 | Buy |
| MA 200 | $105.02 | Buy | $114.49 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 66.02 | Neutral |
| Stoch RSI (14) | 16.35 | Buy |
| CCI (20) | 56.34 | Neutral |
| Williams %R (14) | -21.41 | Info |
| MACD (12,26,9) | 0.39 | Buy |
| ROC (12) | 10.25 | Buy |
| Bollinger %B (20,2) | 0.70 | Neutral |
| Stochastic %K (14) | 78.59 | Neutral |
| TRIX (15) | 0.87 | Buy |
| Awesome (5,34) | 23.35 | Buy |
| Ultimate (7,14,28) | 58.43 | Neutral |
| Momentum (10) | 8.71 | Buy |
| Aroon Osc (25) | 48.00 | Buy |
| Hull MA (9) | 190.01 | Sell |
| ADX (14) | 33.35 | Buy |
| ATR (14) | 3.25 | Info |
In the near term, the technical picture is bullish with RSI14 at 80. The stock trades above the SMA50 of $152.10 and above the SMA200 of $99.26, suggesting constructive momentum.
The current price sits at a resistance level of $192.62, while a support level is noted at $144.19. The 30-day range spans from $162.11 to $228.88, indicating meaningful near-term volatility with potential for upside if buyers stay engaged. The security carries an annualized volatility of 50%.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $78.33 | $186.88 | $257.84 | 0% | Neutral | |
| $199.73 | $246.20 | $318.66 | +32% | Bullish | |
| $227.54 | $286.65 | $382.44 | +53% | Bullish | |
| $257.71 | $330.52 | $451.62 | +77% | Bullish | |
| $283.32 | $369.13 | $514.66 | +98% | Bullish | |
| $352.91 | $466.41 | $661.87 | +150% | Bullish | |
| $427.35 | $572.31 | $825.17 | +206% | Bullish | |
| $469.57 | $636.68 | $931.33 | +241% | Bullish | |
| $500.23 | $686.24 | $1,017.29 | +267% | Bullish | |
| $527.28 | $731.47 | $1,097.87 | +291% | Bullish | |
| $883.23 | $1,288.21 | $2,037.22 | +589% | Bullish | |
| $1,883.36 | $2,988.30 | $5,104.05 | +15.0x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $78.33 | $186.88 | $222.90 | +0.00% |
| August 2026 | $164.57 | $193.13 | $231.92 | +3.34% |
| September 2026 | $170.34 | $201.03 | $243.60 | +4.09% |
| October 2026 | $171.59 | $203.47 | $248.43 | +1.21% |
| November 2026 | $170.51 | $203.01 | $249.45 | -0.22% |
| December 2026 | $174.56 | $208.61 | $257.84 | +2.76% |
Click any year to see its month-by-month RVMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Revolution Medicines, Inc.'s 2026 outlook centres on $186.88, within a $78.33 to $257.84 range. That marks a 0% change versus current levels. Price action looks broadly range-bound.
By 2027, RVMD could reach as high as $318.66, with a base case around $246.20 and support toward $199.73 — roughly +32% from $186.88. Buyers look set to stay in control over this stretch.
Expect RVMD to range from $227.54 to $382.44 through 2028. The $286.65 average target implies a +53% move from current prices. That is up +16% on the projected 2027 average. Momentum favours further upside here.
The RVMD price prediction for 2029 points to an average of $330.52 (low $257.71, high $451.62) — a potential gain of +77% on today's $186.88. Buyers look set to stay in control over this stretch.
In 2030, RVMD is projected to trade between $283.32 and $514.66, averaging $369.13 — a potential gain of +98% from today's $186.88. That is up +12% on the projected 2029 average. Momentum favours further upside here.
Revolution Medicines, Inc.'s 2031 outlook centres on $466.41, within a $352.91 to $661.87 range. That is up +26% on the projected 2030 average. That marks a +150% change versus current levels. Buyers look set to stay in control over this stretch.
By 2032, RVMD could reach as high as $825.17, with a base case around $572.31 and support toward $427.35 — roughly +206% from $186.88. Momentum favours further upside here.
Expect RVMD to range from $469.57 to $931.33 through 2033. The $636.68 average target implies a +241% move from current prices. That is up +11% on the projected 2032 average. Buyers look set to stay in control over this stretch.
The RVMD price prediction for 2034 points to an average of $686.24 (low $500.23, high $1,017.29) — a potential gain of +267% on today's $186.88. Momentum favours further upside here.
In 2035, RVMD is projected to trade between $527.28 and $1,097.87, averaging $731.47 — a potential gain of +291% from today's $186.88. That is up +7% on the projected 2034 average. Buyers look set to stay in control over this stretch.
Revolution Medicines, Inc.'s 2040 outlook centres on $1,288.21, within a $883.23 to $2,037.22 range. That is up +76% on the projected 2035 average. That marks a +589% change versus current levels. Momentum favours further upside here.
By 2050, RVMD could reach as high as $5,104.05, with a base case around $2,988.30 and support toward $1,883.36 — roughly +15.0x from $186.88. Buyers look set to stay in control over this stretch.
Investing $1,000 in RVMD today (≈ 5.351027 RVMD) could be worth
$15,990.47
+$14,990.47 (+1499%) by 2050 · US Dollar
Based on the average projected RVMD price of $2,988.3 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in RVMDwould be worth at today's price.
$1,000 invested in RVMD on Jul 10, 2025 (≈ 25.974026 RVMD) would be worth
$4,854.03
+$3,854.03 (+385.4%) today · 4.85× · US Dollar
Based on a RVMD entry price of $38.5 vs. today's $186.88.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $189.24 | $987.53 | -1.2% |
| 1 month ago | $144.19 | $1,296.07 | +29.6% |
| 3 months ago | $96.43 | $1,937.99 | +93.8% |
| 6 months ago | $117.17 | $1,594.95 | +59.5% |
| 1 year ago | $38.5 | $4,854.03 | +385.4% |
| All time (5.0y) ago | $29.94 | $6,241.82 | +524.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our RVMD forecast.
Our base-case forecast reaches $370.00 around 2031.
Implied market cap at $370.00: $78.66B
The multi-year forecast shows a bullish trajectory with the 2026 avg price at $192.62 and then substantial upside thereafter. By 2030, the avg price is projected at $357.12 with a max of $515.34 and a min of $266.48, for an ROI of 85.4% and bullish sentiment.
In 2040, the forecast envisions an avg price of $1,228.85, a max of $2,049.54, a min of $796.06, and an ROI of 538 with bullish sentiment continuing.
By 2050, the avg price is projected to $2,875.86, with a max of $5,234.24, a min of $1,671.52, and an ROI of 1393, sustaining a bullish outlook. These figures are estimates and not guarantees, and they reflect potential upside under the assumed conditions of the forecast.
Tap a question to reveal the answer.
Avg $357.12; min $266.48; max $515.34; ROI 85.4; sentiment bullish.
Forecast data show bullish sentiment from 2027 onward with rising avg prices and ROIs (e.g., 2027 avg $249.33, ROI 29.4; 2030 avg $357.12, ROI 85.4; 2040 avg $1,228.85, ROI 538; 2050 avg $2,875.86, ROI 1393). These are estimates, not guarantees.
Yes, the 2030 forecast max is $515.34, which exceeds $500.
Current price is $192.62; market cap is $40.95B.
RSI14 is 80; 30-day range low $162.11, high $228.88; Support $144.19; Resistance $192.62; SMA50 $152.10; SMA200 $99.26.
Revolution Medicines, Inc. Community Discussion
0Share your Revolution Medicines, Inc. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.